Caryophyllene oxide

CAS No. 1139-30-6

Caryophyllene oxide( —— )

Catalog No. M17836 CAS No. 1139-30-6

Caryophyllene oxide is isolated from Aegle marmelos, with anti-inflammatory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Caryophyllene oxide
  • Note
    Research use only, not for human use.
  • Brief Description
    Caryophyllene oxide is isolated from Aegle marmelos, with anti-inflammatory activity.
  • Description
    Caryophyllene oxide is isolated from Aegle marmelos, with anti-inflammatory activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    GlyT
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1139-30-6
  • Formula Weight
    220.36
  • Molecular Formula
    C15H24O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (453.82 mM)
  • SMILES
    C[C@@]12CC[C@@H]3[C@H](CC3(C)C)C(=C)CC[C@H]1O2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sain S, et al. Antiinflamm Antiallergy Agents Med Chem. 2014 Mar;13(1):45-55.
molnova catalog
related products
  • Org 25543 hydrochlor...

    Org 25543 hydrochloride is a potent and selective glycine transporter type 2 (GlyT2) inhibitor (IC50 = 16 nM for hGlyT2). Displays no activity at GlyT1 or 56 other common biological targets (≥ 100 μM), in a glycine uptake assay in CHO cells.

  • LY2365109 hydrochlor...

    LY2365109 hydrochloride is a potent and selective GlyT1 inhibitor, with an IC50 of 15.8 nM for glycine uptake in cells over-expressing hGlyT1a.

  • AMG 747

    A nanomolar potent, selective, and orally bioavailable glycine transporter type-1 (GlyT1) inhibitor for the treatment of negative symptoms associated with schizophrenia.